BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22086995)

  • 1. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.
    Kamphuis LS; Lam-Tse WK; Dik WA; van Daele PL; van Biezen P; Kwekkeboom DJ; Kuijpers RW; Hooijkaas H; van Laar JA; Bastiaans J; Baarsma GS; van Hagen PM
    Am J Respir Crit Care Med; 2011 Nov; 184(10):1214-6. PubMed ID: 22086995
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcoidosis and tocilizumab: is there a link?
    Bustamente L; Buscot M; Marquette CH; Roux C
    Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.
    Au S; Mirsaeidi M; Aronson IK; Sweiss NJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):249-51. PubMed ID: 25363227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect.
    Kotze PG; de Barcelos IF; da Silva Kotze LM
    J Crohns Colitis; 2013 Dec; 7(11):e599-600. PubMed ID: 23849401
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
    Korta DZ; Ochieng P; Fishman D; Katz SE
    Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
    Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
    Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TNFα blocking agents and sarcoidosis: an update].
    Toussirot E; Pertuiset E
    Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for refractory pulmonary sarcoidosis.
    Minnis PA; Poland M; Keane MP; Donnelly SC
    Ir J Med Sci; 2016 Nov; 185(4):969-971. PubMed ID: 26428728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary sarcoidosis.
    Baughman RP
    Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
    McDonnell MJ; Rutherford RM; O'Regan A
    J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
    Marcella S; Welsh B; Foley P
    Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for sarcoidosis.
    Viaene E; Thomeer M; Slabbynck H; Wuyts W
    Acta Clin Belg; 2012; 67(2):83-7. PubMed ID: 22712162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.
    Lahmer T; Knopf A; Lanzl I; Heemann U; Thuermel K
    Rheumatol Int; 2012 Aug; 32(8):2367-70. PubMed ID: 21644042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis-like granulomatosis of the hypopharynx as a complication of anti-TNF therapy.
    Christoforidou A; Goudakos J; Bobos M; Lefkaditis E; Vital V; Markou K
    Am J Otolaryngol; 2013; 34(3):268-72. PubMed ID: 23357593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study.
    Knopf A; Lahmer T; Chaker A; Stark T; Hofauer B; Pickhard A; Thürmel K; Bas M
    Head Neck; 2013 May; 35(5):715-9. PubMed ID: 22730039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab for the treatment of refractory acne conglobata.
    Sand FL; Thomsen SF
    JAMA Dermatol; 2013 Nov; 149(11):1306-7. PubMed ID: 24048280
    [No Abstract]   [Full Text] [Related]  

  • 17. Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.
    Jung JH; Kim JH; Song GG
    Z Rheumatol; 2017 May; 76(4):372-374. PubMed ID: 28124746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.
    Baughman RP; Lower EE; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):76-89. PubMed ID: 19382527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis.
    Behnes M; Akin I; Borggrefe M; Traunwieser D; Neuser H; Mashayekhi K
    Circulation; 2015 Jan; 131(4):e26-8. PubMed ID: 25623129
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment to the article: infliximab for treating sarcoidosis patients, Portuguese experience.
    Morais A
    Rev Port Pneumol; 2011; 17(2):94-5. PubMed ID: 21477573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.